Circuit Clinical improves clinical trial participation based on the belief that research provides new treatment options in trusted community care settings. We use technology and research expertise to increase patient and physician access while supporting medical advancements.
MD Prescreen is a concierge service powered by research trained medical experts and designed to optimize lead generation into highly qualified referrals.
A phase 1/2 study to evaluate an investigational product's safety, tolerability, and efficacy in patients with type 1 diabetes mellitus. This three-part study had an overall enrollment goal of 17 participants. Circuit partnered with a large industry-leading biotech company to support pre-screening recruitment leads with MD Prescreen.
A multi-phase and multi-indication portfolio of three randomized acute pain management studies for a single compound. A phase 2 study for painful diabetic peripheral neuropathy, a phase 2 study for acute pain after bunionectomy, and a phase 3 study for acute pain after abdominoplasty. In collaboration with the sponsor, Circuit developed a phone screening tool based on protocol inclusion and exclusion criteria, along with a referral screener, all in accordance with the IRB.
Want to learn about MD Prescreen? Reach out to us.